Cardiovascular risk of nonsteroidal anti-inflammatory drugs and classical and selective cyclooxygenase-2 inhibitors: a meta-analysis of observational studies

dc.contributor.author	Martín Arias, Luis H.
dc.contributor.author	Martín González, Antonio
dc.contributor.author	Sanz Fadrique, Rosario
dc.contributor.author	Salgueiro Vázquez, Esther
dc.date.accessioned	2019-01-30T07:57:17Z
dc.date.available	2019-01-30T07:57:17Z
dc.date.issued	2019
dc.identifier.citation	Journal of Clinical Pharmacology, 59(1), p. 55-73 (2019); doi:10.1002/jcph.1302
dc.identifier.issn	0091-2700
dc.identifier.uri	http://hdl.handle.net/10651/49680
dc.format.extent	p. 55-73
dc.language.iso	eng
dc.relation.ispartof	Journal of Clinical Pharmacology
dc.rights	© 2018, The American College of Clinical Pharmacology
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053377595&doi=10.1002%2fjcph.1302&partnerID=40&md5=4627844e8ce4cf9f07c1d7316c9daae8
dc.title	Cardiovascular risk of nonsteroidal anti-inflammatory drugs and classical and selective cyclooxygenase-2 inhibitors: a meta-analysis of observational studies
dc.type	journal article
dc.identifier.doi	10.1002/jcph.1302
dc.relation.publisherversion	http://dx.doi.org/10.1002/jcph.1302

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.